Equitable Holdings (EQH) COO Reports 6,790-Share Sale Under 10b5-1 Plan
Rhea-AI Filing Summary
Jeffrey J. Hurd, Chief Operating Officer of Equitable Holdings, Inc. (EQH), reported a sale of 6,790 shares of the issuer's common stock on 08/15/2025. The sale was effected under a Rule 10b5-1 trading plan adopted May 1, 2025, and executed in multiple trades at prices ranging from $53.79 to $54.78, with a weighted average price of $54.0928.
After the reported disposition, the filing shows the reporting person beneficially owned 88,677.78 shares (the total includes restricted stock units). The Form 4 was signed by an attorney-in-fact on 08/19/2025.
Positive
- Transaction executed under a Rule 10b5-1 trading plan, adopted May 1, 2025, indicating preauthorization
- Full disclosure of weighted average sale price range ($53.79 to $54.78) and weighted average price ($54.0928)
- Post-transaction beneficial ownership reported (88,677.78 shares), including restricted stock units
Negative
- Insider disposition of 6,790 shares on 08/15/2025, representing a reduction in reported beneficial ownership
- Sale executed in multiple trades, which may prompt questions from some investors despite 10b5-1 plan status
Insights
TL;DR: Insider sale of 6,790 shares was executed under a pre-established 10b5-1 plan; ownership remains disclosed at 88,677.78 shares.
This Form 4 documents a routine disposition by the COO via a Rule 10b5-1 plan, indicating the trades were pre-authorized on May 1, 2025. The sale occurred across multiple executions with a reported weighted average price of $54.0928. From an investor-impact perspective, the disclosure increases transparency about insider holdings but does not by itself indicate unusual timing or undisclosed information because the plan was adopted before the transaction date.
TL;DR: The transaction appears compliant with Section 16 reporting and Rule 10b5-1 procedures, reducing potential governance concerns.
The Form 4 explicitly states the sale was made pursuant to a 10b5-1 trading plan, which supports an affirmative defense under Rule 10b5-1(c). The filing includes the weighted average sale price range and confirms inclusion of restricted stock units in the post-transaction beneficial ownership total. Documentation of counsel signature further supports formal execution and filing compliance.